Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Today on The Balancing Act, we go behind the scenes at Chicago The Musical and into the kitchen with Chef Stuart for some tantalizing Mediterranean recipes.

First, as a celebration of 20 years of razzle dazzle, the Broadway fixture Chicago The Musical continues to wow audiences across the country. For our Broadway Balances America series, correspondent Amber Milt goes behind the scenes with the creative team, former leading ladies — and actually makes a cameo in the show as one of the cell block girls! For a show that stands chin-deep in dirty deeds, it’s one heck of a good time.

Next, cancel those reservations, Chef Stuart O’Keeffe is in the kitchen with bistro-inspired Mediterranean recipes made with high-quality olive oils and balsamic vinegars from Star Fine Foods. From a Mediterranean crescent ring filled with chicken caprese pasta to roasted red pepper and olive bruschetta, these recipes featuring STAR’s quality ingredients will inspire you to put on your chef’s hat.

Plus, Columbia College is an online university that offers affordability and flexible learning options. Online courses at Columbia College are held in six sessions per year, with students able to select from 27 accredited online degree programs and more than 350 accredited online classes each session.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments